Structure of the catalytic region of human complement protease C1s: study by chemical cross-linking and three-dimensional homology modeling. 1995

V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
Laboratoire d'Enzymologie Moléculaire, Institut de Biologie Structurale Jean-Pierre Ebel (CEA-CNRS), Grenoble, France.

C1s is a multidomain serine protease that is responsible for the enzymatic activity of C1, the first component of the classical pathway of complement. Its catalytic region (gamma-B) comprises two contiguous complement control protein (CCP) modules, IV and V (about 60 residues each), a 15-residue intermediary segment, and the B chain (251 residues), which is the serine protease domain. With a view to identify domain-domain interactions within this region, the gamma-B fragment of C1s, obtained by limited proteolysis with plasmin, was chemically cross-linked with the water-soluble carbodiimide 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide; then cross-linked peptides were isolated after CNBr cleavage and thermolytic digestion. N-Terminal sequence and mass spectrometry analyses allowed us to identify two cross-links between Lys 405 of module V and Glu 672 of the B chain and between Glu 418 of the intermediary segment and Lys 608 of the B chain. Three-dimensional modeling of the CCP modules IV and V and of the catalytic B chain was also carried out on the basis of their respective homology with the 16th and 5th CCP modules of complement factor H and type I serine proteases. The information provided by both the chemical cross-linking studies and the homology modeling enabled us to construct a three-dimensional model for the assembly of the C-terminal part of the gamma-B region, comprising module V, the intermediary segment, and the B chain. This model shows that module V interacts with the serine protease B chain on the side opposite to both the activation site and the catalytic site. Functional implications of this interaction are discussed in terms of the possible role of module V in the specific recognition and positioning of C4, one of the two substrates of C1s.

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D003173 Complement C1s A 77-kDa subcomponent of complement C1, encoded by gene C1S, is a SERINE PROTEASE existing as a proenzyme (homodimer) in the intact complement C1 complex. Upon the binding of COMPLEMENT C1Q to antibodies, the activated COMPLEMENT C1R cleaves C1s into two chains, A (heavy) and B (light, the serine protease), linked by disulfide bonds yielding the active C1s. The activated C1s, in turn, cleaves COMPLEMENT C2 and COMPLEMENT C4 to form C4b2a (CLASSICAL C3 CONVERTASE). C 1 Esterase,C1 Esterase,C1s Complement,Complement 1 Esterase,Complement 1s,Complement Component 1s,C1s, Complement,Complement, C1s,Component 1s, Complement,Esterase, C 1,Esterase, C1,Esterase, Complement 1
D003196 Computer Graphics The process of pictorial communication, between human and computers, in which the computer input and output have the form of charts, drawings, or other appropriate pictorial representation. Computer Graphic,Graphic, Computer,Graphics, Computer
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D003488 Cyanogen Bromide Cyanogen bromide (CNBr). A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes. Bromide, Cyanogen
D005022 Ethyldimethylaminopropyl Carbodiimide Carbodiimide cross-linking reagent. 1-Ethyl-3-(3-Dimethylaminopropyl)Carbodiimide,3-(3-Dimethylaminopropyl)-1-Ethylcarbodiimide,EDAP-Carbodiimide,Carbodiimide, Ethyldimethylaminopropyl,EDAP Carbodiimide

Related Publications

V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
June 1996, Protein engineering,
V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
August 2004, Journal of the American Society for Mass Spectrometry,
V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
January 2011, Evolutionary bioinformatics online,
V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
April 1998, Journal of biomolecular structure & dynamics,
V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
October 2004, The Journal of biological chemistry,
V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
August 2016, Molecular & cellular proteomics : MCP,
V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
January 2021, Science advances,
V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
September 1996, Nature,
V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
August 2004, Science in China. Series C, Life sciences,
V Rossi, and C Gaboriaud, and M Lacroix, and J Ulrich, and J C Fontecilla-Camps, and J Gagnon, and G J Arlaud
April 1988, Human genetics,
Copied contents to your clipboard!